Home › Funds › Nuveen, LLC › JNJ

Nuveen, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Nuveen, LLC reported holding 13,525,275 shares of JNJ (JOHNSON & JOHNSON) in its Q3 2026 13F filing — a position valued at US$3.58B, representing 0.86% of its reported portfolio and ranking #16 among its reported holdings. Nuveen, LLC has disclosed JNJ holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)13.53M sh
Reported value held$3.58B
Portfolio Weight0.86%
First reportedQ1 2025
Last changeAdd
Updated2026-11-10

Last updated: 2026-11-10 · Source: SEC EDGAR Form 13F-HR

How Nuveen, LLC's JNJ position evolved

Nuveen, LLC first disclosed a stake in JNJ in Q1 2025 at 8,256,079 shares (US$1.37B). The position peaked in Q3 2026 at 13,525,275 shares, worth US$3.58B. Across 7 filings, Nuveen, LLC increased the stake 6 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 13,525,275 shares valued at US$3.58B — an increase of 546,756 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q1 2025 8.26M $1.37B New
Q2 2025 8.99M $1.37B Add
Q3 2025 9.93M $1.84B Add
Q4 2025 10.61M $2.20B Add
Q1 2026 12.49M $3.05B Add
Q2 2026 12.98M $3.30B Add
Q3 2026 13.53M $3.58B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 32 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Nuveen, LLC held JNJ?

Nuveen, LLC has disclosed JNJ holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Nuveen, LLC's current position in JNJ?

As of Q3 2026, Nuveen, LLC holds 13.53M shares of JNJ (JOHNSON & JOHNSON), valued at $3.58B, representing 0.86% of its reported portfolio and ranking #16.

Has Nuveen, LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Nuveen, LLC increased its position in JNJ. The position peaked in Q3 2026 at 13.53M shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.